Table 3.
The ROC Curve Assay of IGFBP7, CEA and a Combination of IGFBP7 and CEA
| Variables | AUC (95% CI) | Sensitivity (%) | Specificity (%) |
|---|---|---|---|
| CRC vs NC | |||
| IGFBP7 | 0.815(0.754–0.877) | 93.9 | 64.5 |
| CEA | 0.541(0.465–0.617) | 78.3 | 29.9 |
| IGFBP7+CEA | 0.815(0.755–0.875) | 99.1 | 57.9 |
| Early stage CRC vs NC | |||
| IGFBP7 | 0.826(0.757–0.896) | 95.8 | 64.5 |
| CEA | 0.545(0.421–0.669) | 79.2 | 29.9 |
| IGFBP7+CEA | 0.829(0.758–0.899) | 95.8 | 57.9 |
Abbreviations: AUC, area under the curve; 95% CI, 95% confidence interval; CRC, colorectal cancer; NC, normal controls.